Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Flurbiprofen transdermal - Tokuhon Corporation

Drug Profile

Flurbiprofen transdermal - Tokuhon Corporation

Alternative Names: Fulruban Pap; Stayban® Pap; Yakuban Tape

Latest Information Update: 26 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Tokuhon Corporation
  • Developer GC-Rise Pharmaceutical; Taisho Toyama Pharmaceutical; Tokuhon Corporation; Tokyo Medical and Dental University
  • Class Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories; Propionic acids
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Inflammatory pain; Muscle pain; Musculoskeletal disorders; Osteoarthritis; Periarthritis; Tendinitis
  • No development reported Pain

Most Recent Events

  • 09 Nov 2018 Taisho Toyama Pharmaceutical and Tokyo Medical and Dental University complete a clinical trial in Osteoarthritis in Japan (PO) (UMIN000024789)
  • 15 Mar 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top